Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”

Detalles Bibliográficos
Autores principales: Xu, Wen-xiong, Peng, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521547/
https://www.ncbi.nlm.nih.gov/pubmed/31187027
http://dx.doi.org/10.1155/2019/2970510
_version_ 1783418983997767680
author Xu, Wen-xiong
Peng, Liang
author_facet Xu, Wen-xiong
Peng, Liang
author_sort Xu, Wen-xiong
collection PubMed
description
format Online
Article
Text
id pubmed-6521547
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65215472019-06-11 Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse” Xu, Wen-xiong Peng, Liang Can J Gastroenterol Hepatol Letter to the Editor Hindawi 2019-05-02 /pmc/articles/PMC6521547/ /pubmed/31187027 http://dx.doi.org/10.1155/2019/2970510 Text en Copyright © 2019 Wen-xiong Xu and Liang Peng. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Xu, Wen-xiong
Peng, Liang
Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_full Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_fullStr Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_full_unstemmed Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_short Response to: Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_sort response to: comment on “48-week outcome after cessation of nucleos(t)ide analogue treatment in chronic hepatitis b patient and the associated factors with relapse”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521547/
https://www.ncbi.nlm.nih.gov/pubmed/31187027
http://dx.doi.org/10.1155/2019/2970510
work_keys_str_mv AT xuwenxiong responsetocommenton48weekoutcomeaftercessationofnucleostideanaloguetreatmentinchronichepatitisbpatientandtheassociatedfactorswithrelapse
AT pengliang responsetocommenton48weekoutcomeaftercessationofnucleostideanaloguetreatmentinchronichepatitisbpatientandtheassociatedfactorswithrelapse

Ejemplares similares